EXHIBIT 10.4 SEMI-EXCLUSIVE LICENSE AGREEMENT THIS SEMI-EXCLUSIVE LICENSE AGREEMENT (hereinafter, "Agreement"), effective as of April 1, 2005 (hereinafter, the "Effective Date"), is made by and between Abbott Laboratories, a corporation of the State...Semi-Exclusive License Agreement • February 13th, 2008 • Whispering Oaks International Inc • Surgical & medical instruments & apparatus • New York
AMENDMENT TO SEMI-EXCLUSIVE LICENSE AGREEMENTSemi-Exclusive License Agreement • November 18th, 2009 • Biocurex Inc • Surgical & medical instruments & apparatus
THIS AMENDMENT TO SEMI-EXCLUSIVE LICENSE AGREEMENT (hereinafter, “Agreement”), effective as of June 1st, 2007 (hereinafter, the “Amendment Date”), is made by and between Abbott Laboratories, a corporation of the State of Illinois, having its principal place of business at 100 Abbott Park Road, Abbott Park, IL 60064-3500 (hereinafter, “Abbott”) and BioCurex Inc., a corporation of the State of Texas, having its principal place of business at 215-7080 River Road, Richmond, BC, Canada, V6X 1X5 (hereinafter, “BioCurex”).
SEMI-EXCLUSIVE LICENSE AGREEMENTSemi-Exclusive License Agreement • February 23rd, 2001 • Seattle Genetics Inc /Wa • Services-commercial physical & biological research • New Jersey
THIS AGREEMENT, effective as Sept. 30, 1993, is between Enzon, Inc. a corporation of the State of Delaware (ENZON) having its principal place of business at 40 Kingsbridge Road, Piscataway, NJ 08854-3998, and Bristol-Myers Squibb Company, a corporation of the State of Delaware (BMS) having a principal place of business at Route 206 and Province Line Road, Princeton, NJ 08540.
SEMI-EXCLUSIVE BNP DIAGNOSTIC LICENSE AGREEMENT between BIOSITE DIAGNOSTICS INCORPORATED and SCIOS INC.Semi-Exclusive License Agreement • March 16th, 2006 • Biosite Inc • In vitro & in vivo diagnostic substances • California
THIS LICENSE AGREEMENT (the “Agreement”) is made effective the 30th day of December, 1996 (the “Effective Date”), by and between BIOSITE DIAGNOSTICS INCORPORATED, a corporation organized under the laws of Delaware with its principal place of business at 11030 Roselle Street, San Diego, California 92121 (“Biosite”), and SCIOS INC., a corporation organized under the laws of the State of Delaware with a principal place of business at 2450 Bayshore Parkway, Mountain View, California 94043 (“Scios”).
ContractSemi-Exclusive License Agreement • September 25th, 2019
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
SEMI-EXCLUSIVE LICENSE AGREEMENTSemi-Exclusive License Agreement • December 5th, 2000 • Seattle Genetics Inc /Wa • Services-commercial physical & biological research • New Jersey
THIS AGREEMENT, effective as Sept. 30, 1993, is between Enzon, Inc. a corporation of the State of Delaware (ENZON) having its principal place of business at 40 Kingsbridge Road, Piscataway, NJ 08854-3998, and Bristol-Myers Squibb Company, a corporation of the State of Delaware (BMS) having a principal place of business at Route 206 and Province Line Road, Princeton, NJ 08540.
